Long-acting Cabotegravir Injectable Pre-exposure Prophylaxis for People Who Inject Drugs

Clinical trial NCT07199335 · RECRUITING

Trial details

NCT number: NCT07199335
Sponsor: Massachusetts General Hospital
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

HIV Substance Use Disorder (SUD)Injection Drug Use

Start date: 2026-02-24
Primary completion: 2028-12-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.